US Patent Issued to Research Institute at Nationwide Children's Hospital on Aug. 19 for "Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2A" (Ohio Inventor)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,928, issued on Aug. 19, was assigned to Research Institute at Nationwide Children's Hospital (Columbus, Ohio).

"Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2A" was invented by Zarife Sahenk (Columbus, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Products and methods for treating limb girdle muscular dystrophy 2A are provided. In the methods, recombinant adeno-associated viruses deliver DNA encoding a protein with calpain 3 activity."

The patent was filed on June 28, 2019, under Application No. 17/255,488.

*For further information, including images, charts and tables, please visit: http...